Latest News about VRDN
Recent news which mentions VRDN
From Benzinga
Dow Surges Over 100 Points; Crude Oil Falls Sharply
August 15, 2022
From Benzinga
Why Viridian Therapeutics Is Trading Higher By Around 58%, Here Are 67 Stocks Moving In Monday's Mid-Day Session
August 15, 2022
From Benzinga
From Benzinga
From Motley Fool
12 Health Care Stocks Moving In Monday's Pre-Market Session
August 15, 2022
From Benzinga
Earnings Scheduled For August 15, 2022
August 15, 2022
From Benzinga
From Benzinga
110 Biggest Movers From Friday
May 16, 2022
From Benzinga
From Benzinga
56 Stocks Moving In Friday's Mid-Day Session
May 13, 2022
From Benzinga
Earnings Scheduled For May 12, 2022
May 12, 2022
From Benzinga
From Benzinga
Earnings Scheduled For March 10, 2022
March 10, 2022
From Benzinga
The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg
March 06, 2022
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
February 18, 2022
From Benzinga
The Daily Biotech Pulse: Liquidia Jumps On New CEO Appointment, Spectrum, Aravive Secure New Funding, Allena To Explore Strategic Alternatives
January 04, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2021
November 18, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2021
October 12, 2021
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
October 12, 2021
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
September 28, 2021
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
September 24, 2021
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
September 22, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.